Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
02:14pm, Tuesday, 15'th Oct 2024
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling around 150 points on Tuesday.
Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market
09:00am, Tuesday, 15'th Oct 2024
NEW YORK , Oct. 15, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for ce
Lexaria Announces $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
08:25am, Tuesday, 15'th Oct 2024
KELOWNA, BC / ACCESSWIRE / October 15, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it
Wall Street On Edge As Nasdaq Nears Record High, Oil Prices Plummet: Strategist Says There's Opportunity If Resilience Continues
06:43am, Tuesday, 15'th Oct 2024
Wall Street mood has become circumspect as traders gear up to receive a slew of earnings reports this week amid the market's record run. The Nasdaq Composite has been a laggard among the major average
Nasdaq-100 Income ETF QQQI Crosses $500 Million
03:12pm, Monday, 14'th Oct 2024
Launched at the end of January, the NEOS Nasdaq 100 High Income ETF (QQQI) recently crossed $500 million in AUM. The fund remains a consistent performer within its category, offering high income and
Stock Market Today: Nasdaq Composite Rises As NVIDIA & AI Stocks Soar
09:46am, Monday, 14'th Oct 2024
At market open, key indexes are generally showing green. Shortly after 9:30 a.m.
Sharps Technology, Inc. Announces Stockholders' Approval of Reverse Stock Split Ratio and Effective Date
08:00am, Monday, 14'th Oct 2024
NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patent
CeriBell IPO: Stock price will be closely watched today as the AI brain-monitoring headband maker debuts on the Nasdaq
05:01pm, Friday, 11'th Oct 2024
CeriBell, a neurodiagnostic startup known for its brain-monitoring headband that can detect seizure activity, is making its market debut on Friday in an IPO that is expected to generate $180.3 million
X3 Holdings Receives Extension to Regain Compliance with the Nasdaq's Minimum Bid Price Requirement
04:30pm, Friday, 11'th Oct 2024
SINGAPORE , Oct. 11, 2024 /PRNewswire/ -- X3 Holdings Co., Ltd. (Nasdaq: XTKG) (the "Company" or "XTKG"), a global provider of digital solutions and technology services spanning diverse industries, to
eHealth, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 11'th Oct 2024
AUSTIN, Texas, Oct. 11, 2024 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace (the "Company"), today announced that on October 9, 2024, the Compens
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 11'th Oct 2024
CAMBRIDGE, Mass., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives o
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Friday, 11'th Oct 2024
SAN FRANCISCO, CA / ACCESSWIRE / October 11, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective October 7, 2024, the Company granted 80,000 restricted
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 11'th Oct 2024
SAN FRANCISCO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercializat
Upstream Bio valued at $1.1 bln as shares jump in Nasdaq debut
12:49pm, Friday, 11'th Oct 2024
Shares of Upstream Bio opened 26.5% above the initial public offering price in their Nasdaq debut on Friday, valuing the drug developer at $1.05 billion.
Nano Labs Resolves Nasdaq Minimum Market Value of Publicly Held Shares Deficiency
08:00am, Friday, 11'th Oct 2024
HANGZHOU, China, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading fabless integrated circuit design company and product solution
